AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (988 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

TULP4 degrades RYBP to enhance DNA damage repair and chemosensitivity of pancreatic ductal adenocarcinoma

Jingyao Daia,1, Su Liub,1, Yangyang Xiec, Yixuan Wangc, Xiyun Biand, Tian Yud, Tiantian Lic, Linchuang Jiac, Zhigang Zhaob,e( ), Zhiqiang Liub( ), Xiaozhi Liud( )
Hepatobiliary Surgery Department, Air Force Medical Center, Beijing 100142, China
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Department of Pathophysiology, School of Basic Medical Science, Tianjin Medical University, Tianjin 300060, China
Tianjin Key Laboratory of Epigenetics for Organ Development in Preterm Infants, Tianjin Fifth Central Hospital, Tianjin 300450, China
Department of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin 300192, China

1 These authors contribute equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

1

Luo W, Tao J, Zheng L, Zhang T. Current epidemiology of pancreatic cancer: challenges and opportunities. Chin J Cancer Res. 2020;32(6):705–719.
Crossref Google Scholar
2

Sherman MH, Beatty GL. Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu Rev Pathol. 2023;18:123–148.
Crossref Google Scholar
3

Pezone A, Olivieri F, Napoli MV, Procopio A, Avvedimento EV, Gabrielli A. Inflammation and DNA damage: cause, effect or both. Nat Rev Rheumatol. 2023;19(4):200–211.
Crossref Google Scholar
4

Halbrook CJ, Pontious C, Kovalenko I, et al. Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer. Cell Metabol. 2019;29(6):1390–1399.e6.
Crossref Google Scholar
5

Luong TT, Bernstein KA. Role and regulation of the RECQL4 family during genomic integrity maintenance. Genes. 2021;12(12):1919.
Crossref Google Scholar
Genes & Diseases
Volume 12 Issue 2,
March 2025
Article number: 101288
DOI: 10.1016/j.gendis.2024.101288
Cite this article:
Dai J, Liu S, Xie Y, et al. TULP4 degrades RYBP to enhance DNA damage repair and chemosensitivity of pancreatic ductal adenocarcinoma. Genes & Diseases, 2025, 12(2): 101288. https://doi.org/10.1016/j.gendis.2024.101288

71

Views

1

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Received: 22 August 2023
Published: 05 April 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Return